Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Influenza

Free Subscription 12.08.2019 2 J Virol 1 PLoS Comput Biol 1 PLoS One 1 Proc Natl Acad Sci U S A 3 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

J Virol

1. DHAKAL S, Klein SL
   Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs.
   J Virol. 2019 Aug 7. pii: JVI.00797-19. doi: 10.1128/JVI.00797.
   PubMed     Text format     Abstract available
   
   
2. LIMBURG H, Harbig A, Bestle D, Stein DA, et al
   TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes.
   J Virol. 2019 Aug 7. pii: JVI.00649-19. doi: 10.1128/JVI.00649.
   PubMed     Text format     Abstract available
   
   

   
   PLoS Comput Biol

3. YANG J, Muller NF, Bouckaert R, Xu B, et al
   Bayesian phylodynamics of avian influenza A virus H9N2 in Asia with time-dependent predictors of migration.
   PLoS Comput Biol. 2019;15:e1007189.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

4. PALEKAR R, Rodriguez A, Avila C, Barrera G, et al
   Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017.
   PLoS One. 2019;14:e0219595.
   PubMed     Text format     Abstract available
   
   

   
   Proc Natl Acad Sci U S A

5. SCHMIDT N, Domingues P, Golebiowski F, Patzina C, et al
   An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.
   Proc Natl Acad Sci U S A. 2019 Aug 7. pii: 1907031116.
   PubMed     Text format     Abstract available
   
   

   
   Vaccine

6. STARK FC, Akache B, Ponce A, Dudani R, et al
   Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
   Vaccine. 2019 Aug 2. pii: S0264-410X(19)30888.
   PubMed     Text format     Abstract available
   
   
7. TZENG TT, Lai CC, Weng TC, Cyue MH, et al
   The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
   Vaccine. 2019 Aug 2. pii: S0264-410X(19)30346.
   PubMed     Text format     Abstract available
   
   
8. NOH JY, Jang YS, Lee SN, Choi MJ, et al
   Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults.
   Vaccine. 2019 Jul 31. pii: S0264-410X(19)30997.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: